F-group (family)
3016.1.1.8 Beta_elim_lyase
Ligands and drugs
187
Member domains
100
with ligand contacts (≤ 4 Å)
53.5% of members
67
with DrugDomain annotations
35.8% of members
37
with a DrugBank compound
19.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3016.1.1.8 belongs to X-group 3016 C-terminal domain in some PLP-dependent transferases, which binds 8.0 ligand superclasses per 20 proteins, broader than 55% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00114 | PLP | Pyridoxal phosphate | 1 |
| DB00133 | SER | Serine | 1 |
| DB02688 | DHA | 2,3-Didehydroalanine | 1 |
| DB03345 | BME | Mercaptoethanol | 1 |
| DB03897 | HPP | Phloretic acid | 1 |
| DB04436 | YOF | 3-Fluoro-L-tyrosine | 1 |
| DB04467 | PP3 | N-(5'-phosphopyridoxyl)-L-alanine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 0JO | 2-{[(E)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene]amino}prop-2-enoic acid | 14 |
| P61 | (2E)-3-(3-fluoro-4-hydroxyphenyl)-2-{[(Z)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4(1H)-ylidene}methyl]imino}propanoic acid | 8 |
| CQG | pyridin-4-ol | 7 |
| BZI | BENZIMIDAZOLE | 6 |
| PLI | (2E)-2-{[(Z)-{3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN-4(1H)-YLIDENE}METHYL]IMINO}PROPANOIC ACID | 5 |
| 9TD | 1-carboxy-1-{[(E)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene]azaniumyl}-2-[(3R)-2-oxo-2,3-dihydro-1H-indol-3-yl]ethan-1-ide | 4 |
| BY3 | (E)-3-[(3S)-3-chloro-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-L-alanine | 4 |
| YQK | (2~{E})-2-[(~{Z})-[2-methyl-3-oxidanyl-5-[[oxidanyl-bis(oxidanylidene)-$l^{6}-phosphanyl]oxymethyl]-1~{H}-pyridin-4-ylidene]methyl]imino-3-[(3~{S})-3-oxidanyl-2-oxidanylidene-1~{H}-indol-3-yl]propanoic acid | 4 |
| CL | CHLORIDE ION | 3 |
| F0G | (E)-N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-L-alanine | 3 |
| Kmetal | POTASSIUM ION | 3 |
| PN9 | (4Z)-4-({[(1E)-1-carboxy-3-(methylsulfanyl)propylidene]azaniumyl}methylidene)-2-methyl-5-[(phosphonooxy)methyl]-1,4-dihydropyridin-3-olate | 3 |
| YAE | (E)-S-ethyl-N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-L-homocysteine | 3 |
| YAR | (2E)-4-(ethylsulfanyl)-2-{[(Z)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4(1H)-ylidene}methyl]imino}butanoic acid | 3 |
| 9PO | PYRIDINE-N-OXIDE | 2 |
| A1ABZ | (2E)-2-{[(Z)-{3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4(1H)-ylidene}methyl]imino}-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid | 2 |
| A1ACN | (E)-N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-L-alanine | 2 |
| CSmetal | CESIUM ION | 2 |
| ESC | 2-AMINO-4-ETHYL SULFANYL BUTYRIC ACID | 2 |
| NAmetal | SODIUM ION | 2 |